Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126783441 | 12678344 | 1 | I | 20160720 | 20160817 | 20160823 | 20160823 | EXP | AU-PFIZER INC-2016392836 | PFIZER | 69.00 | YR | F | Y | 66.50000 | KG | 20160823 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126783441 | 12678344 | 1 | PS | SILDENAFIL CITRATE. | SILDENAFIL CITRATE | 1 | 75 MG, TOTAL DAILY DOSE | U | 20895 | 75 | MG | ||||||||
| 126783441 | 12678344 | 2 | SS | UT-15C SR | TREPROSTINIL DIOLAMINE | 1 | Oral | 1.5 MG, TID | 0 | 1.5 | MG | TID | |||||||
| 126783441 | 12678344 | 3 | SS | BOSENTAN. | BOSENTAN | 1 | 250 MG, TOTAL DAILY DOSE | U | 0 | 250 | MG | ||||||||
| 126783441 | 12678344 | 4 | C | COVERSYL | PERINDOPRIL | 1 | 2.5 MG, TOTAL DAILY DOSE | 0 | 2.5 | MG | |||||||||
| 126783441 | 12678344 | 5 | C | FRUSEMIDE | FUROSEMIDE | 1 | 120 MG, TOTAL DAILY DOSE | 0 | 120 | MG | |||||||||
| 126783441 | 12678344 | 6 | C | ZYLOPRIM | ALLOPURINOL | 1 | 100 MG, TOTAL DAILY DOSE | 0 | 100 | MG | |||||||||
| 126783441 | 12678344 | 7 | C | CALCITROL | CALCITRIOL | 1 | 100 MCG, TOTAL DAILY DOSE | 0 | 100 | UG | |||||||||
| 126783441 | 12678344 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, TOTAL DAILY DOSE | 0 | 20 | MG | |||||||||
| 126783441 | 12678344 | 9 | C | WARFARIN | WARFARIN | 1 | 3 MG, TOTAL DAILY DOSE | 0 | 3 | MG | |||||||||
| 126783441 | 12678344 | 10 | C | BISOPROLOL | BISOPROLOL | 1 | 5 MG, TOTAL DAILY DOSE | 0 | 5 | MG | |||||||||
| 126783441 | 12678344 | 11 | C | PROLIA | DENOSUMAB | 1 | 60 MG, TOTAL DAILY DOSE | 0 | 60 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126783441 | 12678344 | 1 | Pulmonary hypertension |
| 126783441 | 12678344 | 2 | Pulmonary arterial hypertension |
| 126783441 | 12678344 | 3 | Pulmonary hypertension |
| 126783441 | 12678344 | 4 | Hypertension |
| 126783441 | 12678344 | 5 | Pulmonary arterial hypertension |
| 126783441 | 12678344 | 9 | Atrial fibrillation |
| 126783441 | 12678344 | 10 | Myocardial infarction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126783441 | 12678344 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126783441 | 12678344 | Condition aggravated | |
| 126783441 | 12678344 | Right ventricular failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126783441 | 12678344 | 1 | 20160511 | 0 | ||
| 126783441 | 12678344 | 2 | 20160511 | 0 | ||
| 126783441 | 12678344 | 3 | 20120910 | 0 | ||
| 126783441 | 12678344 | 5 | 2006 | 20160722 | 0 | |
| 126783441 | 12678344 | 6 | 2006 | 0 | ||
| 126783441 | 12678344 | 7 | 201502 | 0 | ||
| 126783441 | 12678344 | 8 | 2006 | 0 | ||
| 126783441 | 12678344 | 9 | 2006 | 0 | ||
| 126783441 | 12678344 | 10 | 2006 | 0 | ||
| 126783441 | 12678344 | 11 | 2014 | 0 |